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全員に食欲不振が G2（有害事象共通用語規準 v4.0 
日本語訳 JCOG 版から有害事象のグレードを G で
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Abstract
　This study aimed to clarify the resilience that colon cancer patients who received postoperative adjuvant 
chemotherapy with multiple drugs demonstrated for the completion of treatment, and obtain the suggestion for 
nursing. Six patients who agreed to participate in the study within one year of completion of the multidrug adjuvant 
chemotherapy were recruited, and the data obtained from the interview was analyzed by referring to the method 
of content analysis of Berelson. The results were [ability to strive to alleviate adverse events through anticancer 
drugs] [ability to believe in oneself] [ability to have your own purpose in treatment] [ability to set goals with the aim 
of ending treatment and to endure the present] [ability to trust the doctor ] [ability to positively grasp the disease 
and treatment] [ability to support the support of other people important] and [ability to feed on past experience]. 
Resilience was demonstrated to achieve treatment while actively dealing with the psychological pain caused by the 
uncertainty of the relief and therapeutic effects of painful adverse events resulting from postoperative adjuvant 
chemotherapy with multidrug combination over a long period of time. Support for resilience includes providing 
information that can control adverse events, supporting patients to be able to store energy of mind, doctors 
providing appropriate advice regarding the completion of treatment, and strengthening of social support and 
resources for patients. It was suggested to listen to the patient’s past difficult experiences.
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